23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million. The drugmaker came out…
Dick’s Sporting Goods said Wednesday it’s standing by its full-year guidance, which includes the expected impact from all tariffs…
Macy’s cut its full-year profit guidance on Wednesday even as it beat Wall Street’s quarterly earnings expectations, as the…
Walmart agreed to pay a small fine and promised to ensure its third-party resellers are unable to sell realistic…
The once-solid relationship between President Donald Trump and Apple CEO Tim Cook is breaking down over the idea of…
United Airlines reached an “industry-leading” tentative labor deal for its 28,000 flight attendants, their union said Friday. The deal…
The Federal Trade Commission voted to dismiss a lawsuit filed in the last days of the Biden administration that…
President Donald Trump on Friday cleared the merger of U.S. Steel and Nippon Steel, after the Japanese steelmaker’s previous…
Department of Justice officials on Tuesday charged members or associates of an Armenian organized crime ring with stealing more than $83…